CNTA logo

Centessa Pharmaceuticals plc (CNTA)

Profile

Full Name

Centessa Pharmaceuticals plc

Ticker

NASDAQ: CNTA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

May 28, 2021

Indexes

Not included

Website

https://centessa.com

Employees

86

Key Details

Price

$21.81(-3.79%)

Market cap

$2.92B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(-100.00% YoY)

Annual EPS

-$2.06(-30.76% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $21.81
    CNTA price is $21.81

    30-Day Relative Volume

    0.96
    CNTA 30-day relative volume is 0.96

    Price Performance

    Price Most recent change

    -3.79%
    CNTA price was down -3.79% on Sep 12, 2025

    Price YTD change

    +30.21%
    CNTA price is up +30.21% since January 1st

    Price 1-year change

    +44.44%
    CNTA price is up +44.44% year-on-year

    Price 3-year change

    +434.56%
    CNTA price is up +434.56% over the past 3 years

    Price Range

    Price All-time high

    $26.90
    CNTA price is currently -18.92% below its historical high of $26.90

    Price 3-year low

    $3.00
    CNTA price is currently +627.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.92B
    CNTA market capitalization is $2.92 billion

    Market cap 3-year change

    +659.71%
    CNTA market capitalization is up +659.71% over the past 3 years

    Market cap All-time high

    $3.04B
    CNTA market capitalization is currently -3.96% below its historical high of $3.04 billion

    Market cap sector rank

    84.82%
    CNTA market capitalization is higher than 84.82% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +18.32%
    CNTA shares outstanding is up +18.32% year-on-year

    Shares Outstanding 3-Year Change

    +42.12%
    CNTA shares outstanding is up +42.12% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.08
    CNTA beta is 1.08

    200-day SMA

    $15.38
    CNTA price is currently +41.82% above its 200-day simple moving average

    50-day SMA

    $16.68
    CNTA price is currently +30.74% above its 50-day simple moving average

    RSI

    71.00
    CNTA 14-day relative strength index is 71.00

    Volume

    0.96
    CNTA 30-day relative volume is 0.96

    ATR

    $1.16
    CNTA average true range is $1.16

    10-day Historical Volatility

    122.08%
    CNTA 10-day historical volatility is 122.08%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CNTA annual revenue is $0.00

    Revenue Analysts estimate

    $15.00M
    CNTA annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    -100%
    CNTA annual revenue is down -100% year-on-year

    Revenue Sector rank

    28.79%
    CNTA annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$2.06
    CNTA annual earnings per share is -$2.06

    EPS Analysts estimate

    -$1.37
    CNTA annual earnings per share is currently +50.01% higher than the consensus analysts' forecast

    EPS 1-year change

    -30.76%
    CNTA annual earnings per share is down -30.76% year-on-year

    EPS Sector rank

    36.55%
    CNTA annual earnings per share is higher than 36.55% of companies in Healthcare sector

    Profit

    Gross profit

    -$942.40K
    CNTA annual gross profit is -$942.40 thousand

    Gross margin

    -
    CNTA annual gross profit margin value is unknown

    Operating profit

    -$201.14M
    CNTA annual operating income is -$201.14 million

    Operating margin

    -
    CNTA annual operating profit margin value is unknown

    Net income

    -$235.86M
    CNTA annual net profit is -$235.86 million

    Net margin

    -
    CNTA annual net profit margin value is unknown

    Expenses

    Total expenses

    $235.86M
    CNTA annual total expenses is $235.86 million

    Operating expenses

    $200.20M
    CNTA annual total operating expenses is $200.20 million

    Cost of goods sold

    $942.40K
    CNTA annual cost of goods sold is $942.40 thousand

    Selling, general & administrative expenses

    $0.00
    CNTA annual SGA is $0.00

    Depreciation and amortization

    $942.40K
    CNTA annual depreciation & amortization is $942.40 thousand

    Interest expense

    $0.00
    CNTA annual interest expense is $0.00

    Income tax

    $2.85M
    CNTA annual income tax is $2.85 million

    EBIT & EBITDA

    EBIT

    -$201.14M
    CNTA annual earnings before interest & taxes is -$201.14 million

    EBITDA

    -$200.20M
    CNTA annual EBITDA is -$200.20 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $579.50M
    CNTA annual total assets is $579.50 million

    Non current assets

    $40.39M
    CNTA annual long term assets is $40.39 million

    Current assets

    $536.41M
    CNTA annual total current assets is $536.41 million

    Cash and cash equivalents

    $482.18M
    CNTA annual cash & cash equivalents is $482.18 million

    Accounts receivable

    -
    CNTA annual accounts receivable value is unknown

    Inventory

    $0.00
    CNTA annual inventory is $0.00

    Liabilities

    Total liabilities

    $177.95M
    CNTA annual total liabilities is $177.95 million

    Long term liabilities

    $2.73M
    CNTA annual total long term liabilities is $2.73 million

    Current liabilities

    $58.00M
    CNTA annual total current liabilities is $58.00 million

    Accounts payable

    $7.14M
    CNTA annual accounts payable is $7.14 million

    Debt

    Total debt

    $117.23M
    CNTA annual total debt is $117.23 million

    Total debt 1-year change

    +38.58%
    CNTA annual total debt is up +38.58% year-on-year

    Long term debt

    $117.23M
    CNTA annual long term debt is $117.23 million

    Short term debt

    $0.00
    CNTA annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $401.55M
    CNTA annual stockholders equity is $401.55 million

    Book value

    $401.54M
    CNTA annual book value is $401.54 million

    Retained earnings

    -$988.70M
    CNTA annual retained earnings is -$988.70 million

    Working capital

    $478.41M
    CNTA annual working capital is $478.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$142.11M
    CNTA annual cash flow from operations is -$142.11 million

    Cash from operations 1-year change

    +11.71%
    CNTA annual cash flow from operations is up +11.71% year-on-year

    Cash from investing

    $31.28M
    CNTA annual cash flow from investing activities is $31.28 million

    Cash from investing 1-year change

    +124.53%
    CNTA annual cash flow from investing activities is up +124.53% year-on-year

    Cash from financing

    $364.91M
    CNTA annual cash flow from financing activities is $364.91 million

    Cash from financing 1-year change

    +1621.34%
    CNTA annual cash flow from financing activities is up +1621.34% year-on-year

    CAPEX

    CAPEX

    $34.00K
    CNTA annual capital expenditures is $34.00 thousand

    CAPEX 1-year change

    -79.96%
    CNTA annual capital expenditures is down -79.96% year-on-year

    Free Cash Flow

    Free cash flow

    -$142.15M
    CNTA annual free cash flow is -$142.15 million

    Free cash flow 1-year change

    +11.78%
    CNTA annual free cash flow is up +11.78% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CNTA annual gross profit margin value is unknown

    Operating margin

    -
    CNTA annual operating profit margin value is unknown

    Net margin

    -
    CNTA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -50.05%
    CNTA annual return on assets is -50.05%

    ROE

    -73.96%
    CNTA annual return on equity is -73.96%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CNTA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CNTA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.48
    CNTA price to book ratio is 8.48

    PB ratio Sector rank

    86.95%
    CNTA price to book ratio is higher than 86.95% of companies in Healthcare sector

    PS Ratio

    PS ratio

    194.20
    CNTA price to sales ratio is 194.20

    PS ratio Sector rank

    92.57%
    CNTA price to sales ratio is higher than 92.57% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.79B
    CNTA enterprise value is $2.79 billion

    Enterprise value Sector rank

    83.7%
    CNTA enterprise value is higher than 83.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -13.55
    CNTA EV/EBITDA is -13.55

    EV/EBITDA Sector rank

    10.02%
    CNTA EV/EBITDA is higher than 10.02% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    9.25
    CNTA annual current ratio is 9.25

    Quick ratio

    9.25
    CNTA annual quick ratio is 9.25

    Leverage

    Debt to equity

    0.29
    CNTA annual debt to equity ratio is 0.29

    Interest coverage ratio

    -
    CNTA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CNTA piotroski f-score value is unknown

    Altman Z-Score

    7.32
    CNTA altman z-score is 7.32

    Analyst ratings

    Recent major analysts updates

    Sep 3, 25 Wells Fargo
    Overweight
    Aug 12, 25 Chardan Capital
    Buy
    Jul 30, 25 Chardan Capital
    Buy
    Jul 21, 25 Truist Securities
    Buy
    May 28, 25 Needham
    Buy
    May 8, 25 Chardan Capital
    Buy
    Mar 31, 25 Piper Sandler
    Overweight
    Mar 26, 25 Guggenheim
    Buy
    Feb 10, 25 Guggenheim
    Buy
    Jan 7, 25 TD Cowen
    Buy

    Institutional Ownership

    Screeners with CNTA included

    Growing Shares Outstanding
    Mid cap stocks
    Stocks with high beta
    UK stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Centessa Pharmaceuticals plc?
    • Does Centessa Pharmaceuticals plc pay dividends?
    • What sector is Centessa Pharmaceuticals plc in?
    • What industry is Centessa Pharmaceuticals plc in?
    • What country is Centessa Pharmaceuticals plc based in?
    • When did Centessa Pharmaceuticals plc go public?
    • Is Centessa Pharmaceuticals plc in the S&P 500?
    • Is Centessa Pharmaceuticals plc in the NASDAQ 100?
    • Is Centessa Pharmaceuticals plc in the Dow Jones?
    • When was Centessa Pharmaceuticals plc's last earnings report?
    • When does Centessa Pharmaceuticals plc report earnings?

    What is the ticker symbol for Centessa Pharmaceuticals plc?

    The ticker symbol for Centessa Pharmaceuticals plc is NASDAQ:CNTA

    Does Centessa Pharmaceuticals plc pay dividends?

    No, Centessa Pharmaceuticals plc does not pay dividends

    What sector is Centessa Pharmaceuticals plc in?

    Centessa Pharmaceuticals plc is in the Healthcare sector

    What industry is Centessa Pharmaceuticals plc in?

    Centessa Pharmaceuticals plc is in the Biotechnology industry

    What country is Centessa Pharmaceuticals plc based in?

    Centessa Pharmaceuticals plc is headquartered in United Kingdom

    When did Centessa Pharmaceuticals plc go public?

    Centessa Pharmaceuticals plc's initial public offering (IPO) was on May 28, 2021

    Is Centessa Pharmaceuticals plc in the S&P 500?

    No, Centessa Pharmaceuticals plc is not included in the S&P 500 index

    Is Centessa Pharmaceuticals plc in the NASDAQ 100?

    No, Centessa Pharmaceuticals plc is not included in the NASDAQ 100 index

    Is Centessa Pharmaceuticals plc in the Dow Jones?

    No, Centessa Pharmaceuticals plc is not included in the Dow Jones index

    When was Centessa Pharmaceuticals plc's last earnings report?

    Centessa Pharmaceuticals plc's most recent earnings report was on August 12, 2025

    When does Centessa Pharmaceuticals plc report earnings?

    The next expected earnings date for Centessa Pharmaceuticals plc is November 12, 2025
    On this page